中國(guó)生物技術(shù)、癌癥早篩領(lǐng)域前景廣闊

In a new plan to spur the bioeconomy during the 14th Five-Year Plan period (2021-25), the National Development and Reform Commission said it is necessary to promote deep integration of advanced technologies such as genetic testing and disease prevention, and to carry out early screening programs for major diseases, including tumors.

國(guó)家發(fā)展改革委對(duì)外發(fā)布的《“十四五”生物經(jīng)濟(jì)發(fā)展規(guī)劃》提出，要推動(dòng)基因檢測(cè)等先進(jìn)技術(shù)與疾病預(yù)防深度融合，開(kāi)展腫瘤等重大疾病早期篩查。

A report by early detection information provider Zao Dx said 26 financing events were announced last year in China's early cancer detection industry, among which 15 came in at more than 100 million yuan ($14.92 million) each. The combined value of financing reached more than 6.6 billion yuan last year.
早篩網(wǎng)的一份報(bào)告稱(chēng)，2021年中國(guó)癌癥早篩行業(yè)宣布了26項(xiàng)融資活動(dòng)，其中15項(xiàng)融資活動(dòng)的金額均超過(guò)1億元人民幣，2021年融資總額超過(guò)66億元。